LENORBYS
associated with 11 other trademarks
Pharmaceutical products for the treatment of inflammatory diseases, fibrotic diseases, systemic sclerosis, dermatomyositis, systemic lupus erythematos...

Words that describe this trademark:

pharmaceutical products  inflammatory diseases  systemic sclerosis  products treatment  dermatomyositis  diseases  sclerosis  treatment  fibrotic 

Serial Number:

90083029

Mark:

LENORBYS

Status:

Abandoned-No Statement of Use filed

Status Date:

09-26-2022

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceutical products for the treatment of inflammatory diseases, fibrotic diseases, systemic sclerosis, dermatomyositis, systemic lupus erythematosus, and cystic fibrosis

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

12-29-2020

Mark Drawing Status:

Standart Character Mark

Abandon Date:

09-26-2022

Business Name:

CLARK+ELBING LLP

Correspondent Name:

Recent Trademark filings by this company